EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand

Vitchayaporn Uthaibutra, Thida Kaewkod, Pichet Prapawilai, Hataichanok Pandith, Yingmanee Tragoolpua iD

Molecules · 2023

DOI: 10.3390/molecules28030996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Vitchayaporn Uthaibutra und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand. Hauptthemen laut MEDLINE: Antioxidants, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Bee Products Industry Co., Ltd., Chiang Mai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Royal jelly is a nutritious substance produced by the hypopharyngeal and mandibular glands of honeybees. Royal jelly possesses many attractive and beneficial properties which make it an ideal component in medical and pharmaceutical products. The antibacterial, antioxidant, and anti-inflammatory activities of royal jelly from honeybees (Apis mellifera) were determined in this study. Moreover, the total phenolic and flavonoid contents of the royal jelly were also evaluated. The effects of royal jelly on growth inhibition against skin pathogenic bacteria, including Cutibacterium acnes, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, and Corynebacterium spp., were investigated by the agar well diffusion method. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were further determined by the broth dilution method. The results indicated that royal jelly showed antibacterial activity by inhibiting the growth of Gram-positive pathogenic bacteria, while the effectiveness decreased against Gram-negative bacteria. Interestingly, royal jelly from Lamphun (RJ-LP1), and Chiang Mai (RJ-CM1), presented high inhibitory efficacy against C. acnes, MRSA, and S. aureus within 4 h by a time killing assay. Furthermore, the anti-inflammatory properties of royal jelly were tested using RAW264.7 macrophage cells, and results revealed that RJ-LP1 and RJ-CM1 could reduce nitric oxide (NO) production and suppress iNOS gene expression. After testing the antioxidant activity, RJ-CM1 and RJ-CM2 of royal jelly from Chiang Mai had the highest level. Additionally, RJ-CM1 also showed the highest total phenolic and flavonoid content. These findings have brought forward new knowledge of the antibacterial, antioxidant, and anti-inflammatory properties of royal jelly, which will improve clinical and pharmaceutical uses of royal jelly as an alternative therapy for bacterial infections, and also as a dietary supplement product.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntioxidantsMethicillin-Resistant Staphylococcus aureusAnimalsAnti-Bacterial AgentsAnti-Inflammatory AgentsBeesFatty AcidsStaphylococcus aureusThailandSkinMiceCell LineRoyal Jelly

Stichwörter der Autor:innen

anti-inflammatoryantibacterial activityantioxidant activityroyal jellyskin pathogenic bacteria

Substanzen

Anti-Bacterial AgentsAnti-Inflammatory AgentsAntioxidantsFatty AcidsRoyal Jelly

Autor:innen und Institutionen

  • Department of Biology, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Master of Science Program in Applied Microbiology (International Program), Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Graduate School, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Center of Excellence in Materials Science and Technology, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Research Center in Bioresource for Agriculture, Industry, and Medicine, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.

ORCID-Profile: Yingmanee Tragoolpua

Förderung

  • National Research Council of Thailand
  • Bee Products Industry Co., Ltd.
  • Chiang Mai University
  • Center of Excellence in Materials Science and Technology, Faculty of Science
  • the Graduate School, Chiang Mai University

Zitieren

APA

Uthaibutra, V., Kaewkod, T., Prapawilai, P., Pandith, H., & Tragoolpua, Y. (2023). Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand. Molecules. https://doi.org/10.3390/molecules28030996

Vancouver

Uthaibutra V, Kaewkod T, Prapawilai P, Pandith H, Tragoolpua Y. Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand. Molecules. 2023. doi:10.3390/molecules28030996

BibTeX
@article{Uthaibutra2023,
  author = {Uthaibutra, Vitchayaporn and Kaewkod, Thida and Prapawilai, Pichet and Pandith, Hataichanok and Tragoolpua, Yingmanee},
  title = {Inhibition of Skin Pathogenic Bacteria, Antioxidant and Anti-Inflammatory Activity of Royal Jelly from Northern Thailand},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28030996}
}
Kostenlos starten →